A stubbornly elevated inflation and stronger-than-expected readings from the job report have kept investors at a crossroads about the Fed’s next move. During times of macroeconomic uncertainty, investors must look for stocks with strong fundamentals and solid long-term growth prospects available at a cheap valuation.
Given this backdrop, let us probe into Novo Nordisk A/S (NVO), Novartis AG (NVS), and NetScout Systems, Inc. (NTCT) to see if they are worth adding to your portfolio or not.
